Pig-to-Non-human Primate Heart Transplantation: Immunologic Progress Over 20 Years

Journal of Heart and Lung Transplantation

Volumn 26, Issue 3, 2007, Pages 210-218

  Zhu, Xiaocheng ^a   Dor, Frank J M F ^b   Cooper, David K C ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

15 DEOXYSPERGUALIN; ABATACEPT; ACETYLSALICYLIC ACID; ANTIBODY; AZATHIOPRINE; BOVINE SERUM ALBUMIN; CD40 LIGAND MONOCLONAL ANTIBODY; COBROTOXIN; COMPLEMENT COMPONENT C3B RECEPTOR; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN; CYCLOSPORIN A; GALACTOSYLGALACTOSE; GLYCOCONJUGATE; HEPARIN; K76COOH; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NAFAMSTAT MESILATE; SOLUBLE COMPLEMENT RECEPTOR 1; THYMOCYTE ANTIBODY; UNCLASSIFIED DRUG;

ANTIGEN BINDING; BABOON; CONTINUOUS INFUSION; DNA MODIFICATION; DRUG EFFECT; DRUG EFFICACY; DRUG MEGADOSE; DRUG USE; GRAFT REJECTION; GRAFT SURVIVAL; HEART TRANSPLANTATION; HYPERACUTE GRAFT REJECTION; IMMUNOADSORPTION; IMMUNOMODULATION; IMMUNOSUPPRESSIVE TREATMENT; LOW DRUG DOSE; NONHUMAN; OUTCOME ASSESSMENT; PRIMATE; PRIORITY JOURNAL; REVIEW; SWINE; XENOTRANSPLANTATION;

ANIMALS; HEART TRANSPLANTATION; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; PRIMATES; SWINE; TRANSPLANTATION IMMUNOLOGY; TRANSPLANTATION, HETEROLOGOUS;

EID: 33847412847     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healun.2006.12.005     Document Type: Review

References (78)

1. Cooper D.K.C., and Lanza R.P. Xeno-the promise of transplanting animal organs into humans (2000), Oxford University Press, New York 1-274
2. Onions D., Cooper D.K.C., Alexander T.J.L., et al. An assessment of the risk of xenozoonotic disease in pig-to-human xenotransplantation. Xenotransplantation 7 (2000) 143-155
3. Fishman J.A. Xenosis and xenotransplantation: current concepts and challenges. Xenotransplantation 12 (2005) 370
4. Lexer G., Cooper D.K.C., Rose A.G., et al. Hyperacute rejection in a discordant (pig to baboon) cardiac xenograft model. J Heart Transplant 5 (1986) 411-418
5. Cooper D.K.C., Human P.A., Lexer G., et al. Effects of cyclosporine and antibody adsorption on pig cardiac xenograft survival in the baboon. J Heart Transplant 7 (1988) 238-246
6. Alexandre G.P.J., Gianello P., Latinne D., et al. Plasmapheresis and splenectomy in experimental renal xenotransplantation. In: Hardy M.A. (Ed). Xenograft 25 (1989), Elsevier, Amsterdam 259-266
7. Najarian J.S. Experimental xenotransplantation: a personal history. Xenotransplantation 10 (2003) 10-15
8. Leventhal J.R., Dalmasso A.P., Cromwell J.W., et al. Prolongation of cardiac xenograft survival by depletion of complement. Transplantation 55 (1993) 857-865
9. Kobayashi T., Taniguchi S., Neethling F.A., et al. Delayed xenograft rejection of pig-to-baboon cardiac transplants after cobra venom factor therapy. Transplantation 64 (1997) 1255-1261
10. Pruitt S.K., Kirk A.D., Bollinger R.R., et al. The effect of soluble complement receptor type 1 on hyperacute rejection of porcine xenografts. Transplantation 57 (1994) 363-370
11. Kobayashi T., Neethling F.A., Taniguchi S., et al. Investigation of the anti-complement agents, FUT-175 and K76COOH, in discordant xenotransplantation. Xenotransplantation 3 (1996) 237-245
12. Good A.H., Cooper D.K.C., Malcolm A.J., et al. Identification of carbohydrate structures that bind human antiporcine antibodies: implications for discordant xenografting in man. Transplant Proc 24 (1992) 559-562
13. Cooper D.K.C., Good A.H., Koren E., et al. Identification of α-galactosyl and other carbohydrate epitopes that are bound by human anti-pig antibodies: relevance to discordant xenografting in man. Transplant Immunol 1 (1993) 198-205
14. Oriol R., Ye Y., Koren E., and Cooper D.K.C. Carbohydrate antigens of pig tissues reacting with human natural antibodies as potential targets for hyperacute vascular rejection in pig-to-man organ xenotransplantation. Transplantation 56 (1993) 1433-1442
15. Wu A., Buhler L., and Cooper D.K.C. ABO-incompatible organ and bone marrow transplantation. Transplant Int 16 (2003) 291-299
16. Alexandre G.P., Squifflet J.P., De Bruyere M., et al. Present experiences in a series of 26 ABO-incompatible living donor renal allografts. Transplant Proc 19 (1987) 4538-4542
17. Rieben R., Von Allmen E., Korchagina E.Y., et al. Detection, immunoabsorption, and inhibition of cytotoxic activity of anti-αGal antibodies using newly developed substances with synthetic Gal α1-3Gal disaccharide epitopes. Xenotransplantation 2 (1995) 98-106
18. Taniguchi S., Neethling F.A., Korchagina E.Y., et al. In vivo immunoadsorption of anti-pig antibodies in baboons using a specific Galα1-3Gal column. Transplantation 62 (1996) 1379-1384
19. Xu Y., Lorf T., Sablinski T., et al. Removal of anti-porcine natural antibodies from human and nonhuman primate plasma in vitro and in vivo by a Galα1-3Galß1-4ßGlc-X immunoaffinity column. Transplantation 65 (1998) 172-179
20. Kozlowski T., Ierino F.L., Lambrigts D., et al. Depletion of anti-Galα1-3Gal antibody in baboons by specific alpha-Gal immunoaffinity columns. Xenotransplantation 5 (1998) 122-131
21. Buhler L., Awwad M., Basker M., et al. High-dose porcine hematopoietic cell transplantation combined with CD40 ligand blockade in baboons prevents an induced anti-pig humoral response. Transplantation 69 (2000) 2296-2304
22. Buhler L., Yamada K., Kitamura H., et al. Pig kidney transplantation in baboons: anti-Galα1-3Gal IgM alone is associated with acute humoral xenograft rejection and disseminated intravascular coagulation. Transplantation 72 (2001) 1743-1752
23. Watts A., Foley A., Awwad M., et al. Plasma perfusion by apheresis through a Gal immunoaffinity column successfully depletes anti-Gal antibody: experience with 320 aphereses in baboons. Xenotransplantation 7 (2000) 181-185
24. Buhler L., Awwad M., Down J.D., et al. Pig hematopoietic cell chimerism in baboons conditioned with a nonmyeloablative regimen and CD154 blockade. Transplantation 73 (2002) 12-22
25. Cooper D.K.C., Cairns T.D.H., and Taube D.H. Extracorporeal immunoadsorption of αGal antibodies. Xeno 4 (1996) 27-29
26. Kozlowski T., Shimizu A., Lambrigts D., et al. Porcine kidney and heart transplantation in baboons undergoing a tolerance induction regimen and antibody adsorption. Transplantation 67 (1999) 18-30
27. Alwayn I.P.J., Xu Y., Basker M., et al. Effects of specific anti-B and/or anti-plasma cell immunotherapy on antibody production in baboons: depletion of CD20- and CD22-positive B cells does not result in significantly decreased production of anti-αGal antibody. Xenotransplantation 8 (2001) 157-171
28. Bach F.H., Turman M.A., Vercellotti G.M., Platt J.L., and Dalmasso A.P. Accommodation: a working paradigm for progressing toward clinical discordant xenografting. Transplant Proc 23 (1991) 205-207
29. Cooper D.K.C., Ye Y., Niekrasz M., et al. Specific intravenous carbohydrate therapy-a new concept in inhibiting antibody-mediated rejection: experience with ABO-incompatible cardiac allografting in the baboon. Transplantation 56 (1993) 769-777
30. Oglesby T.J., White D., Tedja I., et al. Protection of mammalian cells from complement-mediated lysis by transfection of human membrane cofactor protein and decay-accelerating factor. Trans Assoc Am Phys 104 (1991) 164-172
31. Dalmasso A.P., Vercellotti G.M., Platt J.L., and Bach F.H. Inhibition of complement-mediated endothelial cell cytotoxicity be decay-accelerating factor. Potential for prevention of xenograft hyperacute rejection. Transplantation 52 (1991) 530-533
32. Cozzi E., and White D.J.G. The generation of transgenic pigs as potential organ donors for humans. Nat Med 1 (1995) 964-969
33. Morgan B.P., Berg C.W., and Harris C.L. "Homologous restriction" in complement lysis: roles of membrane complement regulators. Xenotransplantation 12 (2005) 258-265
34. Bhatti F.N., Schmoeckel M., Zaidi A., et al. Three-month survival of hDAF transgenic pig hearts transplanted into primates. Transplant Proc 31 (1999) 958
35. Ye Y., Neethling F.A., Niekrasz M., et al. Evidence that intravenously administered α-galactosyl carbohydrates reduce baboon serum cytotoxicity to pig kidney cells (PK15) and transplanted pig hearts. Transplantation 58 (1994) 330-337
36. Teranishi K., Gollackner B., Buhler L., et al. Depletion of anti-Gal antibodies in baboons by intravenous therapy with bovine serum albumin conjugated to Gal oligosaccharides. Transplantation 73 (2002) 129-139
37. Teranishi K., Alwayn I.P.J., Bühler L., et al. Depletion of anti-Gal antibodies by the intravenous infusion of Gal type 2 and 6 glycoconjugates in baboons. Xenotransplantation 10 (2003) 357-367
38. Diamond L.E., Byrne G.W., Schwarz A., et al. Analysis of the control of the anti-Gal response in a non-human primate by galactose alpha1-3 galactose trisaccharide-polyethylene glycol conjugate. Transplantation 73 (2002) 1780-1787
39. Kuwaki K., Knosalla C., Dor F.J.M.F., et al. Suppression of natural and elicited antibodies in pig-to-baboon heart transplantation using a human anti-CD154 monoclonal antibody-based regimen. Am J Transplant 4 (2004) 363-372
40. McGregor C.G.A., Davies W.R., et al. Cardiac xenotransplantation: recent preclinical progress with 3-month median survival. J Thorac Cardiovasc Surg 130 (2005) 844-851
41. Rood P.P.M., Hara H., Busch J., et al. Incidence and cytotoxicity of antibodies in cynomolgus monkeys directed to nonGal antigens, and their relevance for experimental models. Transplant Int 19 (2006) 158-165
42. Chen G., Starzl T., Sun H., et al. Induced anti-non-Gal antibodies lead to acute humoral xenograft rejection in baboons using α1,3-galactosyltransferase gene-knockout pigs as kidney donors. Nat Med 11 (2005) 1295-1298
43. Ezzelarab M., Ayares D., and Cooper D.K.C. Carbohydrates in xenotransplantation. Immunol Cell Biol 83 (2005) 396-404
44. Lambrigts D., Van Calster P., Xu Y., et al. Pharmacologic immunosuppressive therapy and extracorporeal immunoadsorption in the suppression of anti-αGal antibody in the baboon. Xenotransplantation 5 (1998) 274-283
45. Knosalla C., Gollackner B., Buhler L., et al. Correlation of biochemical and hematological changes with graft failure following pig heart and kidney transplantation in baboons. Am J Transplant 3 (2003) 1510-1519
46. Knosalla C., Ryan D.J.J., Moran K., et al. Initial experience with the human anti-human CD154 monoclonal antibody, ABI793, in pig-to-baboon xenotransplantation. Xenotransplantation 11 (2004) 353-360
47. Kuwaki K., Tseng Y.-L., Dor F.J.M.F., et al. Heart transplantation in baboons using α1,3-galactosyltransferase gene-knockout pigs as donors: initial experience. Nat Med 11 (2005) 29-31
48. Tseng Y.-L., Kuwaki K., Dor F.J.M.F., et al. α1,3-galactosyltransferase gene-knockout pig heart transplantation in baboons with survival approaching six months. Transplantation 80 (2005) 1493-1500
49. Cooper D.K.C., Koren E., and Oriol R. Genetically engineered pigs. Lancet 342 (1993) 682-683
50. Phelps C.J., Koike C., Vaught T.D., et al. Production of α1,3-galactosyltransferase-deficient pigs. Science 299 (2003) 411-414
51. Kolber-Simonds D., Lai L., Watt S.R., et al. α1,3-galactosyltransferase null pigs via nuclear transfer with fibroblasts bearing loss of heterozygosity mutations. Proc Natl Acad Sci USA 19 (2004) 7335-7340
52. Dor F.J.M.F., Tseng Y.-L., Cheng J., et al. α1,3-galactosyltransferase gene-knockout miniature swine produce natural cytotoxic anti-Gal antibodies. Transplantation 78 (2004) 15-20
53. Houser S.L., Kuwaki K., Knosalla C., et al. Thrombotic microangiopathy and graft arteriopathy in pig hearts following transplantation into baboons. Xenotransplantation 11 (2004) 416-425
54. Tai H.-C., Ezzelarab M., Hara H., Ayares D., and Cooper D.K.C. Progress in xenotransplantation following the introduction of gene-knockout technology. Transplant Int 20 (2007) 107-117
55. Dor F.J.M.F., Kuwaki K., Tseng Y.-L., et al. Potential of aspirin to inhibit thrombotic microangiopathy (TM) in α1,3-galactosyltransferase gene-knockout (GalT-KO) pig hearts after transplantation in baboons. Transplant Proc 37 (2005) 489-490
56. Rosenberg J.C., Broersma R.J., Bullemer G., et al. Relationship of platelets, blood coagulation, and fibrinolysis to hyperacute rejection of renal xenografts. Transplantation 8 (1969) 152-161
57. Robson S.C., Cooper D.K.C., and d'Apice A.J.F. Disordered regulation of coagulation and platelet activation in xenotransplantation. Xenotransplantation 7 (2000) 166-176
58. Gollackner B., Goh S.-K., Qawi I., et al. Acute vascular rejection of xenografts: roles of natural and elicited xenoreactive antibodies in activation of vascular endothelial cells and induction of procoagulant activity. Transplantation 77 (2004) 1735-1741
59. Buhler L., Basker M., Alwayn I.P.J., et al. Coagulation and thrombotic disorders associated with pig organ and hematopoietic cell transplantation in nonhuman primates. Transplantation 70 (2000) 1323-1331
60. Mueller N.J., Kuwaki K., Dor F.J.M.F., et al. Reduction of consumptive coagulopathy using porcine cytomegalovirus-free cardiac porcine grafts in pig-to-primate xenotransplantation. Transplantation 78 (2004) 1449-1453
61. Gollackner B., Mueller N.J., Houser S., et al. Porcine cytomegalovirus and coagulopathy in pig-to-primate xenotransplantation. Transplantation 75 (2003) 1841-1847
62. Rose A.G., Cooper D.K.C., Human P.A., Reichenspurner H., and Reichart B. Histopathology of hyperacute rejection of the heart-experimental and clinical observations in allografts and xenografts. J Heart Lung Transplant 10 (1991) 223-224
63. Rose A.G., and Cooper D.K.C. A histopathologic grading system of hyperacute (humoral, antibody-mediated) cardiac xenograft and allograft rejection. J Heart Lung Transplant 15 (1996) 804-817
64. Rose A.G., and Cooper D.K.C. Venular thrombosis is the key event in the pathogenesis of antibody-mediated cardiac rejection. Xenotransplantation 7 (2000) 31-41
65. Kuwaki K., Knosalla C., Dor F.J.M.F., et al. Troponin T levels in baboons with pig heterotopic heart transplants. J Heart Lung Transplant 24 (2005) 92-94
66. Cooper D.K.C., Tseng Y.-L., and Saidman S.L. Allo- and xeno-antibody cross-reactivity in transplantation. Transplantation 77 (2004) 1-5
67. Hara H., Ezzelarab M., Rood P.P.M., et al. Allosensitized humans are at no greater risk of humoral rejection of GT-KO pig organs than other humans. Xenotransplantation 13 (2006) 357-365
68. Wong B.S., Yamada K., Koumi M., et al. Allosensitization does not increase the risk of xenoreactivity to α1,3-galactosyltransferase gene-knockout (GalT-KO) miniature swine in patients on transplantation waiting lists. Transplantation 82 (2006) 314-319
69. Popma S.H., Krasinskas A.M., Szeto W.Y., et al. Allosensitization increases human anti-pig cellular xenoreactivity. Transplant Proc 32 (2000) 954-955
70. Oostingh G.J., Davies H.F., Bradley J.A., and Taylor C.J. Comparison of allogeneic and xenogeneic in vitro T cell proliferative responses in sensitized patients awaiting kidney transplantation. Xenotransplantation 10 (2003) 545-551
71. Ye Y., Luo Y., Kobayashi T., et al. Secondary organ allografting after a primary "bridging" xenotransplant. Transplantation 60 (1995) 19-22
72. Baertschiger R.M., Dor F.J.M.F., Prabharasuth D.D., et al. Absence of humoral and cellular alloreactivity in baboons sensitized to pig antigens. Xenotransplantation 11 (2004) 27-32
73. Tseng Y.-L., Moran K., Dor F.J.M.F., et al. Elicited antibodies in baboons exposed to tissues from α1,3-galactosyltransferase gene-knockout pigs. Transplantation 81 (2006) 1058-1062
74. Kawai T., Cosmi B., Colvin R.B., et al. Mixed allogeneic chimerism and renal allograft tolerance in cynomolgus monkeys. Transplantation 59 (1995) 256-262
75. Spitzer T.R., Delmonico F., Rubin N.T., et al. Combined histocompatibility leukocyte antigen-matched donor bone marrow and renal transplantation for multiple myeloma with end stage renal disease: the induction of allograft tolerance through mixed lymphohematopoietic chimerism. Transplantation 68 (1999) 480-484
76. Tseng Y.-L., Sachs D.H., and Cooper D.K.C. Porcine hematopoietic progenitor cell transplantation in nonhuman primates: a review of progress. Transplantation 79 (2005) 1-9
77. Sandrin M.S., Fodor W.L., Mouhtouris E., et al. Enzymatic remodeling of the carbohydrate surface of a xenogenic cell substantially reduces human antibody binding and complement-mediated lysis. Nat Med 1 (1995) 1261-1267
78. Mirenda V., Golshayan D., Read J., et al. Achieving permanent survival of islet xenografts by independent manipulation of direct and indirect T-cell responses. Diabetes 54 (2005) 1048-1055